TiumBio Co Ltd
KOSDAQ:321550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
TiumBio Co Ltd
Free Cash Flow
TiumBio Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
TiumBio Co Ltd
KOSDAQ:321550
|
Free Cash Flow
-₩16.7B
|
CAGR 3-Years
23%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Free Cash Flow
₩314.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Free Cash Flow
-₩17.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Free Cash Flow
-₩30.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Free Cash Flow
₩90.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Free Cash Flow
-₩61.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
TiumBio Co Ltd
Glance View
TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.
See Also
What is TiumBio Co Ltd's Free Cash Flow?
Free Cash Flow
-16.7B
KRW
Based on the financial report for Dec 31, 2024, TiumBio Co Ltd's Free Cash Flow amounts to -16.7B KRW.
What is TiumBio Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-27%
Over the last year, the Free Cash Flow growth was 57%. The average annual Free Cash Flow growth rates for TiumBio Co Ltd have been 23% over the past three years , -27% over the past five years .
